How much funding has CoSyne Therapeutics raised?

CoSyne Therapeutics has raised $8.8M in total funding, most recently a Seed round.

Who are CoSyne Therapeutics's investors?

CoSyne Therapeutics's investors include Amino Collective, LocalGlobe, Meltwind Advisory, Phoenix Court, Backed.

When was CoSyne Therapeutics founded?

CoSyne Therapeutics was founded in 2021.

Where is CoSyne Therapeutics headquartered?

CoSyne Therapeutics is headquartered in London, United Kingdom.

What industry is CoSyne Therapeutics in?

CoSyne Therapeutics operates in Artificial Intelligence, Biotech, Drug Discovery, Healthcare.

How many employees does CoSyne Therapeutics have?

CoSyne Therapeutics has 11-50 employees.

CoSyne Therapeutics

Upscaling science with polymathic AI

London, United Kingdom · Founded 2021 · $8.8M raised

Artificial Intelligence

Biotech

Drug Discovery

Healthcare

Headquarters: London
Employees: 11–50
Founded: 2021
Business Model: B2B

Website: cosyne.com
Total Funding: $8.8M
Last Round: $7.8M SeedMay 2022
Rounds: 2

About

Vertically integrated AI drug discovery company using polymathic AI foundation models for biology and chemistry. Aims to bring speed to precision medicine by working backwards from the clinic to develop innovative computational and experimental solutions.

Summary

CoSyne Therapeutics is an Artificial Intelligence company based in London, United Kingdom, founded in 2021. It has raised $8.8M in total across 2 rounds, most recently a $7.8M Seed round in May 2022. Investors include Amino Collective, LocalGlobe and Meltwind Advisory.

LinkedIn X (Twitter)